FIELD: medicine.
SUBSTANCE: invention relates to medicine, in particular to cardiology, gerontology and geriatrics, and is intended to predict the deterioration of the condition of an elderly patient with myocardial infarction and senile asthenia syndrome. Determine the content of endothelin-1 and desquamated endothelial cells in the blood. The patient's condition is determined based on the regression model of endothelial dysfunction. With the values of the regression model of endothelial dysfunction equal to 25.72-33.84, the deterioration of the condition of an elderly patient with myocardial infarction and senile asthenia syndrome is predicted.
EFFECT: invention provides the development of a method for predicting the deterioration of the condition of an elderly patient with myocardial infarction and senile asthenia syndrome based on the regression method in terms of endothelial dysfunction - endothelin-1 and desquamated endothelial cells.
1 cl, 1 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR EVALUATING ENDOTHELIAL FUNCTION IN A YOUNG PATIENT | 2006 |
|
RU2321862C1 |
| METHOD OF TREATING PATIENTS WITH CHRONIC GLOMERULONEPHRITIS COMBINED WITH CHRONIC OPISTHORCHIASIS | 2010 |
|
RU2417081C1 |
| METHOD OF ESTIMATING FUNCTIONAL STATUS OF ENDOTHELIUM IN PATIENT WITH ARTERIAL HYPERTENSION AND ITS CEREBRAL COMPLICATIONS | 2008 |
|
RU2380705C1 |
| METHOD FOR DETERMINING THE DEGREE OF RISK OF DEVELOPING CARDIOVASCULAR COMPLICATIONS IN COVID-19 | 2021 |
|
RU2768575C1 |
| METHOD OF TREATING ENDOTHELIAL DYSFUNCTION IN DIABETES MELLITUS | 2019 |
|
RU2703567C1 |
| METHOD FOR PREDICTING CARDIOVASCULAR COMPLICATIONS WITHIN 12 MONTHS AFTER ELECTIVE ENDOVASCULAR MYOCARDIAL REVASCULARIZATION IN PATIENTS WITH ISCHEMIC HEART DISEASE | 2020 |
|
RU2749485C1 |
| METHOD FOR DIAGNOSIS OF ENDOTHELIAL DYSFUNCTION IN WOMEN | 2002 |
|
RU2234094C2 |
| METHOD FOR DETERMINING DIAGNOSTIC CRITERION OF VASCULAR WALL STIFFNESS IN PATIENTS SUFFERING ARTERIAL HYPERTENSION ACCOMPANIED BY ABDOMINAL OBESITY | 2014 |
|
RU2567606C1 |
| METHOD FOR PREDICTING RISK OF DEATH AT HOSPITAL STAGE IN PATIENTS WITHOUT ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION WHO HAVE UNDERGONE NEW COVID-19 CORONAVIRUS INFECTION, TAKING INTO ACCOUNT THEIR IMMUNOLOGICAL STATUS | 2022 |
|
RU2781565C1 |
| METHOD OF CARDIOVASCULAR DISEASE TREATMENT AND PREVENTION WITH USING COWSLIP PRIMROSE HERB EXTRACT | 2008 |
|
RU2353378C1 |
